Editorial
doi: 10.1056/NEJMe1413297.
Epub 2014 Nov 16.
Dual antiplatelet therapy after drug-eluting stents--how long to treat?
Affiliations
- PMID: 25399657
- DOI: 10.1056/NEJMe1413297
Item in Clipboard
Editorial
Dual antiplatelet therapy after drug-eluting stents--how long to treat?
N Engl J Med.
.
No abstract available
Comment in
-
Antiplatelet therapy: risks and benefits of extended DAPT after stenting.Nat Rev Cardiol. 2015 Jan;12(1):1. doi: 10.1038/nrcardio.2014.192. Epub 2014 Dec 2. Nat Rev Cardiol. 2015. PMID: 25445134 No abstract available.
Comment on
-
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.N Engl J Med. 2014 Dec 4;371(23):2155-66. doi: 10.1056/NEJMoa1409312. Epub 2014 Nov 16. N Engl J Med. 2014. PMID: 25399658 Free PMC article. Clinical Trial.
Similar articles
-
Duration of dual antiplatelet therapy after drug-eluting stents.N Engl J Med. 2015 Apr 2;372(14):1372-3. doi: 10.1056/NEJMc1501195. N Engl J Med. 2015. PMID: 25830434 No abstract available.
-
Duration of dual antiplatelet therapy after drug-eluting stents.N Engl J Med. 2015 Apr 2;372(14):1372. doi: 10.1056/NEJMc1501195. N Engl J Med. 2015. PMID: 25830433 No abstract available.
-
Duration of dual antiplatelet therapy after drug-eluting stents.N Engl J Med. 2015 Apr 2;372(14):1372. doi: 10.1056/NEJMc1501195. N Engl J Med. 2015. PMID: 25830432 No abstract available.
-
Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery.Ann Thorac Surg. 2010 Sep;90(3):1040-51. doi: 10.1016/j.athoracsur.2010.04.041. Ann Thorac Surg. 2010. PMID: 20732553 Review.
-
Antiplatelet therapy after placement of a drug-eluting stent: a review of efficacy and safety studies.Clin Ther. 2010 Dec;32(14):2265-81. doi: 10.1016/j.clinthera.2011.01.003. Clin Ther. 2010. PMID: 21353100 Review.
Cited by
-
Antiplatelet therapy: risks and benefits of extended DAPT after stenting.Nat Rev Cardiol. 2015 Jan;12(1):1. doi: 10.1038/nrcardio.2014.192. Epub 2014 Dec 2. Nat Rev Cardiol. 2015. PMID: 25445134 No abstract available.
-
Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials.Catheter Cardiovasc Interv. 2016 Mar;87(4):722-732. doi: 10.1002/ccd.26110. Epub 2015 Aug 26. Catheter Cardiovasc Interv. 2016. PMID: 26309050 Free PMC article.
-
Dual antiplatelet therapy duration after the placement of a drug-eluting stent: what are the data?Curr Treat Options Cardiovasc Med. 2015 Mar;17(3):367. doi: 10.1007/s11936-015-0367-0. Curr Treat Options Cardiovasc Med. 2015. PMID: 25773476
-
Dual Antiplatelet Therapy Duration Following Coronary Stenting. [Corrected].J Am Coll Cardiol. 2015 Mar 3;65(8):787-790. doi: 10.1016/j.jacc.2015.01.004. J Am Coll Cardiol. 2015. PMID: 25720621 Free PMC article. No abstract available.
-
Risks and benefits of triple oral anti-thrombotic therapies after acute coronary syndromes and percutaneous coronary intervention.Drug Saf. 2015 May;38(5):481-91. doi: 10.1007/s40264-015-0286-8. Drug Saf. 2015. PMID: 25829216 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
